Sharekhan

Valiant Laboratories Ltd

Fri 10/10/2025,15:50:5 NSE: VALIANTLAB

₹ 86.93 -1.48 (-1.67%)
BUY NOW Buy Valiant Laboratories Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Valiant Laboratories Ltd

Fri 10/10/2025,16:1:0

Valiant Laboratories Ltd

Fri 10/10/2025,15:50:5 | NSE : VALIANTLAB

₹ 86.93-1.48 (-1.67%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 89.00

Previous Close

₹ 88.41

Volume

11363

Mkt Cap ( Rs. Cr)

₹472.14

High

₹ 89.00

Low

₹ 86.34

52 Week High

₹ 119.16

52 Week Low

₹ 75.16

Book Value Per Share

₹ 58.14

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Valiant Laboratories Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

86.93

62

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

62

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Valiant Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Valiant Laboratories - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Oct 2025, 12:45PM Valiant Laboratories Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2

  • Valiant Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Oct 2025, 12:43PM Certificate under 74(5) of SEBI (DP) Regulations , 2018 for the quarter ended September 30, 2025.

  • Valiant Laboratories - Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

    30 Sep 2025, 4:29PM Valiant Laboratories Limited has informed the Exchange about Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requiremen

  • Valiant Laboratories - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulatio

    30 Sep 2025, 4:25PM Please find enclosed.

  • Valiant Laboratories - Trading Window

    29 Sep 2025, 1:00PM Valiant Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulati

  • Valiant Laboratories - Shareholders meeting

    26 Sep 2025, 3:45PM Valiant Laboratories Limited has submitted the Exchange a copy of Scrutinizers report and Voting Results of Annual General Meeting held on September

  • Valiant Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    26 Sep 2025, 3:38PM Scrutinizer's Report and Voting Results of 4th AGM of Valiant Laboratories Limited.

  • Valiant Laboratories - Change in Management

    25 Sep 2025, 5:50PM Valiant Laboratories Limited has informed the Exchange about change in Management

  • Valiant Laboratories - Shareholders meeting

    25 Sep 2025, 5:44PM Valiant Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 25, 2025

  • Valiant Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    26 Sep 2025, 3:38PM Scrutinizer's Report and Voting Results of 4th AGM of Valiant Laboratories Limited.

  • Valiant Laboratories - Announcement under Regulation 30 (LODR)-Change in Management

    25 Sep 2025, 5:48PM Change in management.

  • Valiant Laboratories - Shareholder Meeting / Postal Ballot-Outcome of AGM

    25 Sep 2025, 5:40PM Proceedings of 4th AGM of Valiant Laboratories limited held through VC/OAVM.

  • Valiant Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    26 Sep 2025, 3:38PM Scrutinizer's Report and Voting Results of 4th AGM of Valiant Laboratories Limited.

  • Valiant Laboratories - Copy of Newspaper Publication

    3 Sep 2025, 3:19PM Valiant Laboratories Limited has informed the Exchange about copy of Newspaper Publication on completion of dispatch of the Annual Report for the FY 2

  • Valiant Laboratories - Updates

    1 Sep 2025, 9:07PM Valiant Laboratories Limited has informed the Exchange regarding 'Letter to shareholders under Regulation 36(1)(b) of SEBI (LODR) Regulations 2015'.

  • Valiant Laboratories - Shareholders meeting

    1 Sep 2025, 9:03PM Valiant Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 2025

  • Valiant Laboratories - Letter To Shareholders

    1 Sep 2025, 8:47PM Letter to shareholders under Regulation 36(1)(b) of SEBI (LODR) Regulations, 2015

  • Valiant Laboratories - Notice Of 4Th Annual General Meeting

    1 Sep 2025, 8:37PM Notice and Annual Report of 4th AGM

  • Valiant Laboratories - Reg. 34 (1) Annual Report.

    1 Sep 2025, 8:34PM Annual Report for FY 2024-2025

  • Valiant Laboratories - Copy of Newspaper Publication

    28 Aug 2025, 12:24PM Valiant Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

  • Valiant Laboratories - Copy of Newspaper Publication

    13 Aug 2025, 4:58PM Valiant Laboratories Limited has informed the Exchange about Copy of Newspaper Publication regarding basis of allotment of Equity Shares under Rights

  • Valiant Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended August 11, 2025

    12 Aug 2025, 8:02PM As of August 2025, 74.94% is owned by Indian Promoters and 25.06% by Public. <p align=justify> Top five Promoters holding highest number of shares of

  • Valiant Laboratories - General Updates

    11 Aug 2025, 5:58PM Valiant Laboratories Limited has informed the Exchange about Allotment of Equity Shares on Rights Basis

  • Valiant Laboratories - Announcement under Regulation 30 (LODR)-Allotment

    11 Aug 2025, 5:53PM Allotment of Equity Shares on Rights Basis.

  • Valiant Laboratories - Copy of Newspaper Publication

    9 Aug 2025, 7:57PM Valiant Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

  • Valiant Laboratories posts Q1 net profit of Rs 1.82 cr

    8 Aug 2025, 5:20PM The company reported standalone net profit during the quarter stood at Rs 1.82 crore compared to net loss of Rs 1.01 crore in the previous year quarte

  • Valiant Laboratories - Change in Director(s)

    8 Aug 2025, 5:12PM Valiant Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.

  • Valiant Laboratories - Announcement under Regulation 30 (LODR)-Change in Directorate

    8 Aug 2025, 5:10PM Change in Designation of Director.

  • Valiant Laboratories - Change in Auditors

    8 Aug 2025, 5:07PM Valiant Laboratories Limited has informed the Exchange regarding Change in Auditors of the company.

  • Valiant Laboratories - Appointment Of Secretarial Auditor.

    8 Aug 2025, 5:05PM Appointment of Secretarial Auditor.

  • Valiant Laboratories - Outcome of Board Meeting

    8 Aug 2025, 4:55PM Outcome of Board Meeting Dated August 08, 2025 - Financial Results for quarter ended June 30, 2025.

  • Valiant Laboratories - Outcome of Board Meeting

    8 Aug 2025, 4:51PM Valiant Laboratories Limited has informed the Exchange regarding Board meeting held on August 08, 2025 for the Financial Results of quarter ended Jun

  • Valiant Laboratories - Outcome Of Board Meeting Dated August 08, 2025-Financial Results For Quarter Ended June 30, 2025

    8 Aug 2025, 4:49PM Outcome of Board Meeting dated August 08, 2025- Financial Results For Quarter Ended June 30, 2025

  • Valiant Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Dated August 08, 2025 - Financial Results For Quart

    8 Aug 2025, 4:44PM Outcome of Board Meeting Dated August 08, 2025 - Financial Results for quarter ended June 30, 2025.

  • Valiant Laboratories - Board Meeting Intimation for Financial Results (Standalone And Consolidated) For The Quarter Ended Jun

    5 Aug 2025, 4:47PM Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 ,inter alia, to consider

  • Valiant Laboratories - Copy of Newspaper Publication

    24 Jul 2025, 3:36PM Valiant Laboratories Limited has informed the Exchange about Newspaper Advertisement for Rights issue of the company

  • Valiant Laboratories - Submission Of Letter Of Offer For Rights Issue Of Fully Paid-Up Equity Shares Of Valiant Laboratories

    17 Jul 2025, 6:04PM Submission of Letter of Offer for Rights Issue of Fully Paid-up Equity Shares of Valiant Laboratories Limited

  • Valiant Laboratories - General Updates

    17 Jul 2025, 6:01PM Valiant Laboratories Limited has informed the Exchange about Submission of Letter of Offer for Rights Issue of Fully Paid-up Equity Shares.

  • Valiant Laboratories - Updates

    16 Jul 2025, 4:18PM Valiant Laboratories Limited has informed the Exchange regarding 'ISIN for Rights Entitlements for Rights Issue'.

  • Valiant Laboratories - Intimation Of ISIN For Right Entitlements For The Purpose Of Right Issue

    16 Jul 2025, 4:13PM Intimation of ISIN for Right Entitlements

  • Valiant Laboratories - Alteration Of Capital and Fund Raising-XBRL

    15 Jul 2025, 6:25PM Valiant Laboratories Limited has informed the Exchange regarding Issuance of securities

  • Valiant Laboratories - Rights Issue Of Equity Shares - Record Date July 19, 2025

    15 Jul 2025, 6:23PM Rights issue of Equity shares - Record date July 19, 2025

  • Valiant Laboratories - Corporate Action-Outcome of Right issue

    15 Jul 2025, 6:19PM The Rights Issue Committee of the Company at its meeting dated July 15, 2025 has considered and approved the terms of Rights Issue of Equity Shares

  • Valiant Laboratories - Record Date

    15 Jul 2025, 6:16PM Valiant Laboratories Limited has informed the Exchange that Record date for the purpose of Rights is 19-Jul-2025.

  • Valiant Laboratories - Committee Meeting Updates

    15 Jul 2025, 6:14PM Valiant Laboratories Limited has informed the Exchange regarding Outcome of Committee Meeting held on July 15, 2025.

  • Valiant Laboratories - Rights Issue

    15 Jul 2025, 6:12PM Valiant Laboratories Limited has informed the Exchange that the Rights Issue Committee of the Company at its meeting held on July 15, 2025, has decide

  • Valiant Laboratories - Announcement under Regulation 30 (LODR)-Raising of Funds

    15 Jul 2025, 6:07PM The Rights Issue Committee of the Company at its meeting held today, i.e. on July 15, 2025 has considered and approved the terms of Rights Issue of Eq

  • Valiant Laboratories - Board Meeting Outcome for Approval Of Terms Of Rights Issue Of Equity Shares

    15 Jul 2025, 6:04PM The Rights Issue Committee of the Company at its meeting held today i.e. on July 15, 2025, has, inter alia, considered and approved the Rights Issue P

  • Valiant Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    15 Jul 2025, 3:00PM As of June 2025, 74.94% is owned by Indian Promoters and 25.06% by Public. <p align=justify> Top five Promoters holding highest number of shares of Va

  • Valiant Laboratories - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    11 Jul 2025, 4:27PM Valiant Laboratories Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2

  • Valiant Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    11 Jul 2025, 4:24PM Certificate under 74(5) for the Quarter ended June 30, 2025
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Valiant Laboratories Ltd stock 

Name March-25 March-24 March-23 March-22
Assets 293.7833 296.2821 159.89 132.141
Liabilities 293.7833 296.2821 159.89 132.141
Equity 43.45 43.45 32.56 16.28
Gross Profit -4.676 -8.4083 35.09 42.318
Net Profit -2.1502 0.3403 28.998 27.496
Cash From Operating Activities -21.9012 48.7819 22.956 2.251
NPM(%) -1.61 0.18 8.68 9.43
Revenue 133.3618 182.0525 333.91 291.523
Expenses 138.0378 190.4608 298.82 249.205
ROE(%) -0.68 0.1 9.18 8.7

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Valiant Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 802.40 1.40 72.75 49.48 301.39 0.62
Lotus Eye Hospital and Institute Ltd 119.83 -1.08 386.55 180.30 3.55 0.00
Vaishali Pharma Ltd 11.06 -0.36 368.67 1131.11 3.13 0.00
Astec Lifesciences Ltd 765.75 0.28 0.00 170.03 -604.77 0.00

Company Info

The Company was originally formed as a partnership firm under Indian Partnership Act, 1932, under the name and style of "M/s Bharat Chemicals" pursuant to the deed of partnership dated October 17, 1980. Subsequently, the partnership firm, M/s. Bharat Chemicals was converted into a public limited company under the provisions of the Companies Act with the name "Valiant Laboratories Limited" pursuant to certificate of incorporation dated August 16, 2021 issued by Central Registration Centre, Registrar of Companies. The corporate identity number of the Company is U24299MH2021PLC365904.Key events and milestones :1980- Formed M/s. Bharat Chemicals (a partnership firm)1981- Acquired plot No. L-30 in the Tarapur Industrial Area, Palghar, Maharashtra on leasehold basis admeasuring about 1,000 sq. mtrs1982- Commenced manufacture of Paracetamol2004-05- Acquired additional Plot Nos. L-28, L-28 (part), L-29 and L-13 at Tarapur Industrial Area, Palghar, Maharashtra collectively admeasuring about 3,000 sq.mtrs2015- The annual revenue from operations crossed Rs.500 million2021- Converted from partnership firm into a public limited company- The annual revenue from operations crossed Rs.1,000 million2022- The annual revenue from operations crossed Rs.2,000 million- Formed the wholly owned subsidiary, VASPL to diversify the business activities

The Company was originally formed as a partnership firm under Indian Partnership Act, 1932, under the name and style of "M/s Bharat Chemicals" pursuant to the deed of partnership dated October 17, 1980. Subsequently, the partnership firm, M/s. Bharat Chemicals was converted into a public limited company under the provisions of the Companies Act with the name "Valiant Laboratories Limited" pursuant to certificate of incorporation dated August 16, 2021 issued by Central Registration Centre, Registrar of Companies. The corporate identity number of the Company is U24299MH2021PLC365904.Key events and milestones :1980- Formed M/s. Bharat Chemicals (a partnership firm)1981- Acquired plot No. L-30 in the Tarapur Industrial Area, Palghar, Maharashtra on leasehold basis admeasuring about 1,000 sq. mtrs1982- Commenced manufacture of Paracetamol2004-05- Acquired additional Plot Nos. L-28, L-28 (part), L-29 and L-13 at Tarapur Industrial Area, Palghar, Maharashtra collectively admeasuring about 3,000 sq.mtrs2015- The annual revenue from operations crossed Rs.500 million2021- Converted from partnership firm into a public limited company- The annual revenue from operations crossed Rs.1,000 million2022- The annual revenue from operations crossed Rs.2,000 million- Formed the wholly owned subsidiary, VASPL to diversify the business activities

Read More

Parent Organisation

Valiant Laboratories Ltd.

Founded

06/08/2021

Managing Director

Mr.Santosh S Vora

NSE Symbol

VALIANTLABEQ

FAQ

The current price of Valiant Laboratories Ltd is ₹ 86.93.

The 52-week high for Valiant Laboratories Ltd is ₹ 89.00 and the 52-week low is ₹ 86.34.

The market capitalization of Valiant Laboratories Ltd is currently ₹ 472.14. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Valiant Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Valiant Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Valiant Laboratories Ltd shares.

The CEO of Valiant Laboratories Ltd is Mr.Santosh S Vora, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT